Home » Topics » BioWorld Science

BioWorld Science
RSS

Medshine Discovery patents nitroimidazole derivatives

Feb. 6, 2018

Lilly identifies new JAK1 inhibitors

Feb. 6, 2018

Redx Pharma initiates phase I/IIa trial of RXC-004 in hard to treat cancers

Feb. 6, 2018

First patient dosed in phase Ib/II aldoxorubicin combination study

Feb. 6, 2018

V1B receptor antagonism may enhance alcohol dependency treatment

Feb. 6, 2018

EMA accepts Epidiolex MAA for review

Feb. 6, 2018

Fibrocell Science submits IND for gene therapy candidate for scleroderma

Feb. 6, 2018

FDA clears Trethera's TRE-515 IND

Feb. 6, 2018

Jupiter Orphan Therapeutics preparing INDs for Jotrol

Feb. 6, 2018

Survival endpoint met with nab-paclitaxel regimen in biliary tract cancer trial

Feb. 6, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...